Search

Amber D. Steele

Examiner (ID: 11314, Phone: (571)272-5538 , Office: P/1676 )

Most Active Art Unit
1658
Art Unit(s)
1639, 1654, 1676, 1658
Total Applications
1278
Issued Applications
622
Pending Applications
159
Abandoned Applications
534

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 4880467 [patent_doc_number] => 20080153850 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-26 [patent_title] => 'Adamantyl Derivates as P2x7 Receptor Antagonists' [patent_app_type] => utility [patent_app_number] => 11/574343 [patent_app_country] => US [patent_app_date] => 2005-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 44064 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0153/20080153850.pdf [firstpage_image] =>[orig_patent_app_number] => 11574343 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/574343
Adamantyl Derivates as P2x7 Receptor Antagonists Aug 28, 2005 Abandoned
Array ( [id] => 5820080 [patent_doc_number] => 20060024393 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-02 [patent_title] => 'Antimicrobial prevention and treatment of human immunodeficiency virus and other infectious diseases' [patent_app_type] => utility [patent_app_number] => 11/202986 [patent_app_country] => US [patent_app_date] => 2005-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23195 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0024/20060024393.pdf [firstpage_image] =>[orig_patent_app_number] => 11202986 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/202986
Antimicrobial prevention and treatment of human immunodeficiency virus and other infectious diseases Aug 11, 2005 Abandoned
Array ( [id] => 4740684 [patent_doc_number] => 20080234337 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-25 [patent_title] => 'Preventive and/or Remedy for Hyperkalemia Containing Ep4 Agonist' [patent_app_type] => utility [patent_app_number] => 11/660048 [patent_app_country] => US [patent_app_date] => 2005-08-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 23281 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0234/20080234337.pdf [firstpage_image] =>[orig_patent_app_number] => 11660048 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/660048
Preventive and/or Remedy for Hyperkalemia Containing Ep4 Agonist Aug 8, 2005 Abandoned
Array ( [id] => 4570255 [patent_doc_number] => 07858610 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-12-28 [patent_title] => 'Preventive and/or remedy for lower urinary tract diseases containing EP4 agonist' [patent_app_type] => utility [patent_app_number] => 11/660043 [patent_app_country] => US [patent_app_date] => 2005-08-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 25030 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 98 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/858/07858610.pdf [firstpage_image] =>[orig_patent_app_number] => 11660043 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/660043
Preventive and/or remedy for lower urinary tract diseases containing EP4 agonist Aug 8, 2005 Issued
Array ( [id] => 5297253 [patent_doc_number] => 20090012179 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-08 [patent_title] => 'Use of Tyrphostins to Stimulate Neurite Outgrowth' [patent_app_type] => utility [patent_app_number] => 11/658618 [patent_app_country] => US [patent_app_date] => 2005-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 13203 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0012/20090012179.pdf [firstpage_image] =>[orig_patent_app_number] => 11658618 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/658618
Use of Tyrphostins to Stimulate Neurite Outgrowth Aug 3, 2005 Abandoned
Array ( [id] => 4916371 [patent_doc_number] => 20080096972 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-04-24 [patent_title] => 'COMPOUND FORMULATIONS OF 2-AMINO-1, 3-PROPANEDIOL COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 11/572028 [patent_app_country] => US [patent_app_date] => 2005-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6849 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0096/20080096972.pdf [firstpage_image] =>[orig_patent_app_number] => 11572028 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/572028
COMPOUND FORMULATIONS OF 2-AMINO-1, 3-PROPANEDIOL COMPOUNDS Jul 28, 2005 Abandoned
Array ( [id] => 7518494 [patent_doc_number] => 07972595 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-07-05 [patent_title] => 'Methods and compositions for protecting and treating at least one muscarinic receptor from dysfunction not resulting from oxidative stress, toxic actions of metals or infectious agents by administering a pyrophosphate analog' [patent_app_type] => utility [patent_app_number] => 11/191901 [patent_app_country] => US [patent_app_date] => 2005-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 10631 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/972/07972595.pdf [firstpage_image] =>[orig_patent_app_number] => 11191901 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/191901
Methods and compositions for protecting and treating at least one muscarinic receptor from dysfunction not resulting from oxidative stress, toxic actions of metals or infectious agents by administering a pyrophosphate analog Jul 27, 2005 Issued
Array ( [id] => 4711735 [patent_doc_number] => 20080300261 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-04 [patent_title] => 'Arylacetic Acids and Related Compounds for Treatment of Alzheimer\'s Disease' [patent_app_type] => utility [patent_app_number] => 11/658242 [patent_app_country] => US [patent_app_date] => 2005-07-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17303 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0300/20080300261.pdf [firstpage_image] =>[orig_patent_app_number] => 11658242 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/658242
Arylacetic Acids and Related Compounds for Treatment of Alzheimer's Disease Jul 18, 2005 Abandoned
Array ( [id] => 5236128 [patent_doc_number] => 20070128285 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-07 [patent_title] => 'Pharmaceutical composition for oral administration' [patent_app_type] => utility [patent_app_number] => 10/566829 [patent_app_country] => US [patent_app_date] => 2005-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6638 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0128/20070128285.pdf [firstpage_image] =>[orig_patent_app_number] => 10566829 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/566829
Pharmaceutical composition for oral administration Jul 11, 2005 Abandoned
Array ( [id] => 4840380 [patent_doc_number] => 20080280866 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-13 [patent_title] => 'Method of Treating or Sepsis' [patent_app_type] => utility [patent_app_number] => 11/658116 [patent_app_country] => US [patent_app_date] => 2005-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 9619 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0280/20080280866.pdf [firstpage_image] =>[orig_patent_app_number] => 11658116 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/658116
Method of Treating or Sepsis Jul 6, 2005 Abandoned
Array ( [id] => 4867496 [patent_doc_number] => 20080146555 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-19 [patent_title] => 'Uses of Kinase Inhibitors and Compositions Thereof' [patent_app_type] => utility [patent_app_number] => 11/629638 [patent_app_country] => US [patent_app_date] => 2005-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 50352 [patent_no_of_claims] => 104 [patent_no_of_ind_claims] => 37 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0146/20080146555.pdf [firstpage_image] =>[orig_patent_app_number] => 11629638 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/629638
Uses of Kinase Inhibitors and Compositions Thereof Jun 16, 2005 Abandoned
Array ( [id] => 5813912 [patent_doc_number] => 20060084085 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-20 [patent_title] => 'Methods and compositions for modulating Bax-mediated apoptosis' [patent_app_type] => utility [patent_app_number] => 11/154293 [patent_app_country] => US [patent_app_date] => 2005-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 46238 [patent_no_of_claims] => 68 [patent_no_of_ind_claims] => 21 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0084/20060084085.pdf [firstpage_image] =>[orig_patent_app_number] => 11154293 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/154293
Methods and compositions for modulating Bax-mediated apoptosis Jun 15, 2005 Abandoned
Array ( [id] => 5063620 [patent_doc_number] => 20070225260 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-09-27 [patent_title] => 'Amino-Propanol Derivatives' [patent_app_type] => utility [patent_app_number] => 11/568645 [patent_app_country] => US [patent_app_date] => 2005-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7959 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0225/20070225260.pdf [firstpage_image] =>[orig_patent_app_number] => 11568645 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/568645
Amino-propanol derivatives May 24, 2005 Issued
Array ( [id] => 4814042 [patent_doc_number] => 20080194673 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-14 [patent_title] => 'Environment-Friendly Pollution-Proof Agent' [patent_app_type] => utility [patent_app_number] => 11/629814 [patent_app_country] => US [patent_app_date] => 2005-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 9735 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0194/20080194673.pdf [firstpage_image] =>[orig_patent_app_number] => 11629814 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/629814
Environment-Friendly Pollution-Proof Agent May 22, 2005 Abandoned
Array ( [id] => 8543433 [patent_doc_number] => 08318724 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-11-27 [patent_title] => 'Small molecule inhibitors of MRP1 and other multidrug transporters' [patent_app_type] => utility [patent_app_number] => 11/579779 [patent_app_country] => US [patent_app_date] => 2005-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 6402 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11579779 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/579779
Small molecule inhibitors of MRP1 and other multidrug transporters May 12, 2005 Issued
Array ( [id] => 4670460 [patent_doc_number] => 20080045520 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-21 [patent_title] => 'Substituted Pyrrolidine Derivative' [patent_app_type] => utility [patent_app_number] => 11/596318 [patent_app_country] => US [patent_app_date] => 2005-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29343 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 27 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0045/20080045520.pdf [firstpage_image] =>[orig_patent_app_number] => 11596318 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/596318
Substituted pyrrolidine derivative May 12, 2005 Issued
Array ( [id] => 7225833 [patent_doc_number] => 20050255161 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-17 [patent_title] => 'Method for the long term stabilization of labile compounds at room temperature in pharmaceutical preparations containing water' [patent_app_type] => utility [patent_app_number] => 11/125545 [patent_app_country] => US [patent_app_date] => 2005-05-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8319 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0255/20050255161.pdf [firstpage_image] =>[orig_patent_app_number] => 11125545 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/125545
Method for the long term stabilization of labile compounds at room temperature in pharmaceutical preparations containing water May 8, 2005 Abandoned
Array ( [id] => 6930851 [patent_doc_number] => 20050281886 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-22 [patent_title] => 'Particles for the delivery of active agents' [patent_app_type] => utility [patent_app_number] => 11/123958 [patent_app_country] => US [patent_app_date] => 2005-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 10765 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0281/20050281886.pdf [firstpage_image] =>[orig_patent_app_number] => 11123958 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/123958
Particles for the delivery of active agents May 5, 2005 Abandoned
Array ( [id] => 102238 [patent_doc_number] => 07727961 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-06-01 [patent_title] => 'Antioxidant constituents' [patent_app_type] => utility [patent_app_number] => 11/118368 [patent_app_country] => US [patent_app_date] => 2005-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 8389 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/727/07727961.pdf [firstpage_image] =>[orig_patent_app_number] => 11118368 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/118368
Antioxidant constituents May 1, 2005 Issued
Array ( [id] => 4432827 [patent_doc_number] => 07897579 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-03-01 [patent_title] => 'Use of a compound comprising D-mannoheptulose and/or perseitol for treating and preventing innate immunity modification diseases' [patent_app_type] => utility [patent_app_number] => 11/587961 [patent_app_country] => US [patent_app_date] => 2005-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11081 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/897/07897579.pdf [firstpage_image] =>[orig_patent_app_number] => 11587961 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/587961
Use of a compound comprising D-mannoheptulose and/or perseitol for treating and preventing innate immunity modification diseases Apr 28, 2005 Issued
Menu